Subject
The American Journal of Cardiology is a biweekly peer-reviewed scientific journal in the field of cardiology and general cardiovascular disease. The editor-in-chief was William C. Roberts from 1982 to 2022; then he resigned and was replaced by Subhash Banerjee. It supersedes the Transactions of the American College of Cardiology which was published from 1951 to 1957 and the Bulletin of the American College of Cardiology, but it should not be confused with the Journal of the American College of Cardiology. Source: Wikipedia (en)
Editions published in American Journal of Cardiology 200
Too many entities requested (38133). Only 200 are displayed.
-
Triglycerides and Triglyceride-Rich Lipoproteins in the Causal Pathway of Cardiovascular Disease
-
Gender Differences of Thromboembolic Events in Atrial Fibrillation
-
A Systematic Review and Collaborative Meta-Analysis to Determine the Incremental Value of Copeptin for Rapid Rule-Out of Acute Myocardial Infarction
-
Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial
-
Clinical factors associated with high-risk carotid plaque features as assessed by magnetic resonance imaging in patients with established vascular disease (from the AIM-HIGH Study).
-
Practice implications of the Atrial Fibrillation Guidelines
-
Body mass index, playing position, race, and the cardiovascular mortality of retired professional football players
-
Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival
-
Congestive heart failure and diabetes mellitus: balancing glycemic control with heart failure improvement
-
Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapy
-
Diagnosis of pulmonary embolism in the coronary care unit
-
Relation of Taser (electrical stun gun) deployment to increase in in-custody sudden deaths
-
Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis
-
Predictors of on-duty coronary events in male firefighters in the United States
-
Patterns of aspirin dosing in non-ST-elevation acute coronary syndromes in the CRUSADE Quality Improvement Initiative
-
Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention
-
Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes
-
Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction
-
Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials
-
Effect of ranitidine on the antiplatelet effects of aspirin in healthy human subjects
-
Assessment of bleeding events in clinical trials--proposal of a new classification
-
Impact of iodinated contrast injections on percent diameter coronary arterial stenosis and implications for trials of intracoronary pharmacotherapies in patients with ST-elevation myocardial infarction
-
Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study)
-
Long-term versus short-term clopidogrel therapy in patients undergoing coronary stenting (from the Randomized Argentine Clopidogrel Stent [RACS] trial)
-
Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis
-
Endothelin-1 and prevalent coronary heart disease in older men and women (the Rancho Bernardo Study)
-
Preventing macrovascular complications in type 2 diabetes mellitus: glucose control and beyond
-
Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation
-
Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction
-
Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease
-
Frequency of and inappropriate treatment of misdiagnosis of acute aortic dissection
-
Safety considerations with omega-3 fatty acid therapy
Subject - wd:Q2208417